Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (31 quarters reported)
$95.4M in Q4 2018 → $40.8M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Aquestive Therapeutics Inc | 100.0% | Unchanged | 9,810,958 | $40.8M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 11, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 13, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 17, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 14, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 14, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 15, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 13, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed November 12, 2024
No position changes this quarter.
Loading...
